PrincipalSavano Capital Partners
Kyle has over eight years of private/growth equity investing, M&A, and advisory with venture/growth-stage, mid-market, and large-cap companies primarily in technology and tech-enabled services. Kyle joined Savano in 2016 and is based in Washington, DC.
Before joining Savano, Kyle worked at both Golden Gate Capital in San Francisco and The Halifax Group in Washington, DC. He began his career at J.P. Morgan in their Technology, Media, and Telecom group in New York.
Kyle earned a S.B. from the Massachusetts Institute of Technology in Electrical Engineering and Computer Science with minors in Management and Political Science.
PrincipalAmerican Family Ventures
Drew is the NY based Principal at American Family Ventures, a $200m Venture Capital firm backed by American Family Insurance.
He was previously with AXA US in Strategy and M&A and assisted in the development of and then joined AXA Strategic Ventures. Drew also co-founded and led CalendarFly.com, an education technology company and has been an active member of the NYC startup community since 2008.
He also has a deep finance background, getting his start in FX and analysis of esoteric structured finance products. He has led publicly traded restructurings, capital raising, and partnership negotiations on three continents including in North America (US and Canada), Asia (China and Hong Kong) and Europe (France).
AssociateF-Prime Capital Partners
Jessica is an Associate at F-Prime Capital and focuses primarily on the biopharmaceutical and medical technology sectors.
Prior to joining F-Prime in 2015, Jessica was an engagement manager in McKinsey and Company's Boston office, where she focused on pharmaceuticals and medical products and advised companies across a range of strategic, organizational, and operational topics. She began her career at MIT Lincoln Laboratory in the Biodefense Systems group, where she worked on developing novel techniques for the detection of biological agents.
Jessica holds a Ph.D. in genetics from Harvard University and received her BS in biology from Duke University, graduating summa cum laude.
Venture PartnerScout Ventures
Nisa Amoils is an active early stage investor, Board advisor and entrepreneur. She is a member of New York Angels where she invests in a variety of technology and is the co-chair of the frontier technology committee which encompasses AR/VR, robotics, drones, AI, driverless cars, autonomous innovations, cybersecurity, remote sensing, blockchain and other disruptive technologies.
She also has sector and investment expertise in entertainment, beauty, mobile, marketplaces and digital media. She has startup operational experience in areas such as strategic and digital marketing, business development, product and package development, distribution, staffing, fundraising, management and legal.
She is a regular judge/panelist on CNBC, MSNBC and Fox and does podcasts on investing. She is a speaker at conferences such as Venture Summit, the Women in Tech Summit, RoboUniverse and Women's Innovation conferences. She is a mentor at XRC Labs, Grand Central Tech, The Vinetta Project and MenHERnyc. She is a regular judge for the Wharton Business Plan Competition and sits on the Board of the Penn Design School. She is a frequent blogger on investing in frontier technologies.
Prior to this, she spent many years at media companies, including Time Warner and NBC Universal, looking at Internet 1.0 deals, the precursor technologies to VR, and executing strategic partnerships with film and television on behalf of Fortune 500 brands. She was also a practicing corporate lawyer.
She holds a BBA (business) degree from the University of Michigan and a law degree from the University of Pennsylvania.
Venture PartnerBright Capital
Based in New York, Mr. Austin has been a Venture Partner with Bright Capital since 2012, where he focuses broadly on alternative energy, resource and energy efficiency, distributed generation, water, advanced materials and cleantech, providing leadership and strategic guidance for Bright Capital's investment strategy and portfolio companies, including serving on the Boards of Agrivida, QM Power and Ener-G-Rotors.
Prior to Bright Capital, as Managing Director of Chandler Reed LLC, Mr. Austin served as a strategic advisor to CEOs of public and private growth stage companies, new ventures and tech start-ups, and was a consultant at UNDP's Sustainable Energy & Environment Division in the area of sustainable technologies globally, as well as to other UN agencies. He has applied his knowledge of finance and marketing, intellectual property, technology commercialization and strategy across a broad and diverse range of industries. Earlier, Mr. Austin has been a serial tech entrepreneur in the fields of electro-optics, medical devices, and materials manufacturing systems. As a start-up entrepreneur, he has patents issued in 30 countries and has won international design awards.
Mr. Austin is an advisor to tech start-up incubators and accelerators, and is an Entrepreneur-in-Residence (EIR) with NYSERDA and the SUNY College of Nanoscale Science and Engineering, as well as serving on the National Renewable Energy Lab's (NREL) Investment Advisory Board. Mr. Austin has mentored entrepreneurs in different regions of Africa, and spoken at conferences from Krasnoyarsk to Kingston, from Beijing to Bilbao, on venture investing, entrepreneurship, strategy, innovation and sustainable technologies.
Mark Austin is a graduate of Williams College.
Christina Bechhold Russ
InvestorSamsung NEXT Ventures
Christina Bechhold Russ is an Investor at Samsung NEXT Ventures, based in New York, focused on early stage investments in software and services, particularly in mobility, consumer IoT and fintech.
She is also Co-Founder and Managing Director of Empire Angels, a member led angel group of young professionals investing in technology startups with a focus on supporting young entrepreneurs.
Christina is a Regular Contributor for the Wall Street Journal on startups and small business, a columnist for Inc.com, a mentor at The Brandery and Venture for America and a member of VFA's Rise Committee focused on increasing diversity in entrepreneurship. She is a frequent speaker and panelist at events in the U.S., Europe and Asia, a TEDx speaker, and was recognized by the New York Business Journal as a 2016 Woman of Influence.
Alex, an Investor at SideCar Angels, has broad experience across many industries, and is an innovator in helping organizations leverage technology and information to enhance operations. Current areas of focus include optimizing Contact Center operations and helping implement Modern Consumer Experiences for Enterprises which leverage a hybrid workforce or 3rd party service providers to deliver services.
Alex fundamentally understands the Converged Communication and Interaction space. This entails combining elements of User Experience to integrate both formal and informal communication methods, and leveraging Unified Communications on the web and mobile platforms. Alex helps companies to gain insights around such areas as Contact Center Interaction Management Infrastructure (Chat/Web/Audio/Video), Customer Relationship Management (CRM) and Field Service Automation (FSM), to engage in a data-driven change management process.
In his previous roles, Alex was a member of the Deloitte business consulting team, a CIO for a multinational company, and Founder and CEO of Sentri, Inc. -- one of the nation's top integrators of Microsoft systems. Under Alex's leadership, Sentri achieved the highest accolades from customers, was the regional Microsoft Partner of the Year for 3 consecutive years, and East Coast Microsoft Partner of the Year in 2012. Alex's focus and commitment to excellence resulted in Sentri's successful acquisition by Polycom in 2013.
Since the sale of Sentri, Alex became a co-founder of a successful software company, Dispatch Technologies, which focuses on enabling brands to bring Modern Consumer Experiences to their customers, and to fundamentally change how 3rd party service providers are engaged and managed. Alex is also actively engaged in the angel investment space, as well as provides advisory services to CEOs and Sr. Leadership teams and coaching and mentoring services to tech-oriented startups.
PartnerPartners Healthcare Innovation Fund
Carl's career has spanned over 25 years in the practice and management of innovation to bring new technologies from lab to market.
As a bench scientist and R&D director, he worked at Polaroid Corporation and Hygeia Sciences in the development of photographic and clinical products for both consumer and professional markets. He is an inventor on 6 US patents. He served as a Partner at Integral/Analysis Group, a consulting firm focusing on the management of innovation and growth strategy for clients in healthcare and consumer products. He has been an active private equity investor as a member of Angel Healthcare Investors LLC and is a founder of Mass Medical Angels. He has served on the boards of Quosa [research literature management software], Kasalis [robotics], Combinent [women's health], Infobionic [cardiac monitoring], Annovation [anesthetic agent] and currently sits on the board of Syntimmune [immunotherapy], QPID Health [bioinformatics], LifeImage [diagnostic image sharing], Sebacia [dermatology therapy] and the Sudanese Education Fund [philanthropy].
Carl holds an AB degree from Cornell University and received his PhD in Organic Chemistry from the University of California at Berkeley. He also holds an appointment as Lecturer in the MIT Sloan School of Management teaching various courses on the topic of biomedical enterprise.
Maria Berkman, MD, shares responsibility for the day-to-day operations of Broadview Ventures, including identification and screening of new opportunities, due diligence, negotiation of deal structure, and portfolio company board involvement.
Prior to joining Broadview Ventures Maria was a management consultant at Monitor Group (now Monitor Deloitte), where she specialized in life sciences with a focus corporate strategy, franchise and asset-level commercialization strategy, and competitive strategic planning for a broad range of biopharma clients. Before joining Monitor Group, Maria trained within the Partners HealthCare System at Newton Wellesley Hospital, with a focus on General Surgery. Maria earned her MD from the UCLA School of Medicine, graduating Alpha Omega Alpha with a research focus in cardiothoracic and trauma surgery. Maria earned her MBA from the Anderson School of Management at UCLA.
Maria currently serves as the Board Observer for 480 Biomedical, Apama, BioKier, Cardero, Cardialen, Vascular Graft Solutions and Zumbro Discovery and is a Board Director of FineHeart.
In addition to her role at Broadview Ventures, Maria contributes time as a grant reviewer for the National Science Foundation and is a Strategic Advisory Board Member for the RAD Biomed Accelerator in Tel Aviv, Israel.
Managing PartnerNew Energy Capital Partners
Samuel is a Principal at Digitalis. He received graduate degrees from Cambridge and Oxford University as a Marshall Scholar and an A.B. in Chemistry from Harvard University.
Prior to Digitalis, Samuel was a member of the healthcare and clean energy practices at the Boston Consulting Group.
InvestorNewWorld Capital Group
Brandon Blaesser is an Analyst at NewWorld Capital Group and has worked at the firm since 2014.
Prior to that, Brandon leveraged his LEED AP BD+C accreditation working for TerraCycle in Buenos Aires, Argentina and working for Winn Development's Energy and Sustainability group in Boston, MA.
Brandon graduated from Yale University with a B.A. in Economics and a B.A. in Environmental Studies. Additionally, he holds an Energy Studies certificate from the Yale Climate and Energy Institute.
Managing DirectorTelescopic Ventures
Vaughn Blake is the founder and Managing Partner of Telescopic Ventures.
Telescopic invests across the early stage spectrum -- from pre-seed to series A. The firm is focused on frontier and emerging technologies, especially where those technologies are applied narrowly to industry and enterprise. We have offices in Los Angeles and San Francisco.
Anne has been a member of the Saturn team since 2015.
Prior to joining Saturn, Anne worked as a clinical researcher in the Neurology Department at Massachusetts General Hospital. While at MGH, Anne served as lead coordinator for six ALS and MS clinical trials and examined telehealth and tech opportunities in patient care.
Anne graduated cum laude from Yale College with a degree in Molecular, Cellular, and Developmental Biology, with additional coursework in statistics and economics. While at Yale, Anne conducted clinical and bench research and authored papers on neurology and public health.
Prior professional experience includes work at Saturn portfolio company Knopp Biosciences.
InvestorEcosystem Integrity Fund
Sasha Brown is a Principal at the Ecosystem Integrity Fund. Her responsibilities include investment due diligence, strategy development, deal sourcing, and portfolio company support. She assists with system and sector analysis, firm operations, and financial structuring.
Prior to joining EIF, Sasha was a Principal at NewWorld Capital Group, where she co-led investments including SolarEdge Technologies, which had a successful IPO in 2015, and Astrum Solar, which was sold to Direct Energy.
Sasha serves as Board Director at T-Rex Group and PosiGen Solar Solutions and a Board Observer at Opti RTC. She received a BS in Environmental Engineering from Yale University and an MBA from the Yale School of Management.
Founding PartnerOne Way Ventures
Eveline is an immigrant from Brazil and formerly Director for the Techstars Boston program for the past 3 years.
She launched and was the Managing Partner for Eastlabs, a prominent accelerator in Ukraine that jumpstarted the tech entrepreneurship ecosystem regionally. As CEO for media company Ekonomika, Eveline spearheaded its transformation into a digital hub. She was also CEO for cleantech company APCT.
Prior to her startup and digital journey, Eveline worked 10 years as process and control systems engineer in several multimillion dollar projects for the industrial gas industry. She emigrated from Brazil to US, Luxembourg, Ukraine, and back to the US.
Founder and Managing PartnerThe EdTech Fund
Stan is the founder of the EdTech Fund, investing in Seed stage EdTech companies in K-12 and Higher Ed. Stan has a passion for education. He first became involved in education while leading mergers and acquisitions for McGraw-Hill and then as one of the founding trustees of Equality Charter School, starting with an idea in the heads of three educators and taking the school through start-up phase to now being ranked in the top 3% of all NYC middle schools in math.
He is also a member of the town legislature in Darien, CT, serving on the education committee. His investment experience includes seed stage investments in education, small and large acquisitions as well as many types of partnerships and joint ventures.
Stan has led corporate development departments and activities for large companies such as McGraw-Hill, L-3 Communications and Pitney Bowes. He has also helped smaller established businesses as well as start-ups execute their growth strategies.
Prior to a career in business, Stan was an Airborne Ranger Army officer serving in peacekeeping missions in Bosnia, Kosovo and Macedonia. He is a West Point graduate with a BS in computer science engineering and a double major in German and French, and he holds an MBA in finance from Columbia Business School.
Managing DirectorMcCune Capital
Jason Cahill is an early stage investor, advisor, mentor, and entrepreneur. As managing director of McCune Capital, his interests sit at the intersection of new technology disrupting older industries.
His expertise spans transportation, supply chain, infrastructure, agtech, and cleantech. He is an advisor at Carnegie Mellon University, an advisory board member at SXSW, a mentor at Grand Central Tech's Urban Tech Hub and ERA, and a mentor to Columbia University.
He holds a BS from the University of Maryland and an MBA from Carnegie Mellon University and is a veteran of US Army Special Forces.
Founding Partner1843 Capital
With over 15 years' experience in venture capital and private equity, Tracy is the Founding Partner of 1843 Capital. She is focused on investing in early stage technology companies.
Formerly a partner of a growth capital venture capital fund - Baker Capital and Vice President of Robertson, Stephens, she is also an attorney.
A current Board Member of Marstone, and Sachs Insights, she also proudly serves on the Advisory Boards of both the New York Institute of Technology and the MIT Enterprise Forum, is an Executive Advisor for the Echoing Green Foundation and a Mentor for the BIG Accelerator, Monarq and Techstars KC.
Managing DirectorEnergy Foundry
Sara leads venture investment activity for Energy Foundry, an early-stage venture fund based in Chicago. She maintains an active role with each of the firm's portfolio companies, and sits on the Board of SiNode Systems, Advanced Diamond Technologies and Tank Utility.
Prior to Energy Foundry, Sara built a government advisory practice at Wilson Sonsini Goodrich & Rosati and helped energy startups raise $300M in non-dilutive funding. She has also held roles with GE Energy and environmental consulting firm, GaiaTech.
Sara holds an MBA from the University of Chicago Booth School of Business, and an undergraduate degree from Emory University. In 2015, she was recognized by Midwest Energy News ''40 Under 40.''
Elizabeth Wills Chou
PartnerNew Markets Venture Partners
Elizabeth Chou joined New Markets Venture Partners in 2010 and is a Partner. She is a board director for Kickboard and Questar Assessment and a board observer for BetterLesson, PresenceLearning, Graduation Alliance, and previously for Moodlerooms, Think Through Learning and Three Ring.
Prior to New Markets, Elizabeth was a Senior Associate at The Gladstone Companies, a family of public funds (NASDAQ: GLAD, GAIN, GOOD) providing private equity, debt and real estate financing based in McLean, VA. At Gladstone she invested in and managed equity control and mezzanine debt investments in middle market companies in specialty manufacturing and healthcare services. Prior to Gladstone, Elizabeth was an Account Executive with M&T Bank's Middle Market Commercial and Industrial Lending Group in Philadelphia, PA.
Elizabeth graduated with Honors from Mount Holyoke College, with a major in Politics and received a MBA from Columbia Business School.
Founding MemberAstia Angels NYC
Barbara Clarke has a portfolio of over 45 companies. In addition to Astia Angels and Pipeline Angels, she serves on the investment committees of the Portfolia Funds.
As a management consultant and economist, her professional expertise lies in intellectual property valuation. She has witnessed the challenges and opportunities faced by companies when solving complex, important problems. Complex problems need diversity of thought and advanced problem solving skills.
100% of the companies in her personal portfolio had a woman on the founding team and a majority had a person of color on the founding team. Barbara lives in Boston.
Managing DirectorCorrelation Ventures
David began his venture capital career in 1997.
Prior to founding Correlation Ventures, David was a Managing Director of Hamilton BioVentures, an early-stage venture capital fund based in San Diego. As head of Hamilton's Life Science team, David served on the Board of Directors of such companies as PhotoThera, Transcept (NASDAQ: TSPT), and Egea Biopharmaceuticals (Acquired by Johnson&Johnson).
Previously, David was a Venture Partner at Windamere Venture Partners and President of Forge Medical Ventures, an early-stage incubator funded by Enterprise Partners, Mayfield Fund and Johnson & Johnson Development Corporation. David was the Founder of Spine Wave, a venture-funded medical device company and Director of Business Development of UroMed Corporation (URMD), a venture-funded startup that raised several rounds of venture capital and completed a public offering.
David received an M.B.A. from the Harvard Graduate School of Business Administration and graduated Summa Cum Laude with a B.S. in Biology from Princeton University.
Managing DirectorGE Ventures
Lisa Coca is a member of GE Ventures' Enterprise Practice which invests in start-ups that target corporate productivity and operational efficiency.
Prior to joining GE Ventures, her professional career spanned a number of other disciplines including finance, sales & marketing, strategy, and business development at major financial institutions such as GE Capital, Bankers Trust, and Deutsche Bank. Lisa serves on the Board of BizWorld, a non-profit whose mission is to inspire children to have an entrepreneurial spirit and do amazing things. She is also a member of the Executive Committee for Bay Area Women's Philanthropy Network and serves as a mentor for SHE-CAN.
She graduated with honors from the Wharton School at the University of Pennsylvania, received an MBA from the Stanford Graduate School of Business and lives in Los Altos with her husband and three children.
Managing DirectorRed Bear Angels
Meghan Cross, Red Bear Angels
As Managing Director, Meghan leads the operations and investment team at Red Bear Angels, the angel group investing in companies led by Cornell University alumni. She joined RBA with a decade of growing media & software companies in NY & SF.
As an early Director at StyleCaster Inc., Meghan led the digital media conglomerate's marketing team through the business' exit to She Knows Media.
Prior, Meghan was in PR, helping to build Skype and Foursquare into household names. She draws venture experience from working with Bowery Capital, Foundation Capital, Metamorphic Ventures, and StarVest Partners. She is the founder of Cross Venture Services LLC, a launch advisor to such commerce platforms as Sailo (TechStars '15), Shareswell, and Thursday Boot Co.
Meghan has appeared on CNN's "The Situation Room" with Wolf Blitzer and NBC's "The Today Show," and has contributed to TechCrunch.
Meghan received her B.S. in Fiber & Textile Science from Cornell University and M.B.A. from Columbia Business School, where she was also Steve Blank's TA. She resides in New York City and serves on the junior boards of Lincoln Center and the Facing History Organization.
Sanjit Singh Dang
Sanjit is an Investment Director at Intel Capital. He drives investments in Machine Learning/Artificial Intelligence, Computer Vision, Robotics, eCommerce, Virtual Reality, etc. He has also driven several investments in Big Data, IoT and Cloud Computing. He is on the Board of several companies.
He is currently a Board Member in several startups, including True Fit, Enlighted, Body Labs, Reflektion and Cognitive Operational Systems (Cosy Robo). He has had several Exits within 1 year of investment with excellent financial returns - e.g. VokeVR (acquired within 7 months of investment), Basis Science (Wearables, acquired by Intel) and Maginatics (Cloud Storage, acquired by EMC). He is currently an investor in Cognitive Operational Systems (Computer Vision for Retail), True Fit (eCommerce), DocuSign (eSignature), Reflektion (eCommerce), Body Labs (3D Body Modeling), MongoDB (NoSQL Database), Enlighted (IoT), Mirantis (Cloud Computing), GoodData (SaaS BI) and Arcadia Data (Data Analytics 2.0), to name a few.
Sanjit has the fastest Eng PhD from University of Illinois (2yrs 9mo after undergrad), which he received in 2000 with top research awards. He also attended the Venture Capital Executive program at Haas School of Business, UC Berkeley. He's an invited Speaker at several top events, e.g. TEDx, SURGE/WebSummit, TiECon, ShopTalk, McKinsey leadership event, Silicon Valley Open Doors, SACC, Global Big Data and IoT conferences. He's a mentor at Stanford and Berkeley's Entrepreneurship programs.
Sanjit has over a decade of Exec leadership experience in Product Design, Business Development and Strategy across several domains: Big Data, Natural Language Processing, 3D Camera/Apps, Supply-Chain Analytics and Flash Memory. He has managed $2Bill/year accounts and executed >30 partnership deals in $100M-$2Bill range. Always ahead of the curve, Sanjit worked on Big Data Analytics before industry created the term 'Big Data'. Similarly, he launched 2 online courses during grad school in 1999 and published iconic papers on learnings, way before the MOOC revolution started.
Personally, Sanjit has an interest in film-making. He has made a few short movies and taken courses in script-writing, lighting, editing and production at DeAnza College, Cupertino.
Adam de Sola Pool
Adam is an investor, mentor, and new technologies competition judge with 20 years of experience in clean energy & water and hardware companies. Adam is a Partner in Clean Energy Venture Group, a member of Launchpad Ventures, Walnut Ventures, MIT Angels, and Sloan Angels. Adam Mentors & Judges at the Massachusetts Institute of Technology, Techstars, Northeastern University, CleanTech Open, & MassChallenge. Adam is on the Advisory Board of the International Nanotechnology Center accelerator in Braga Portugal and the MIT Enterprise Forum Polska accelerator in Warsaw Poland.
Formerly, as a venture capitalist Adam helped to start over twenty renewable energy and environmental companies in central Europe. He invested through Environmental Investment Partners which was funded by family and HNW investor money. Additionally, as the former Chairman of the AmCham Energy & Environment Committee he acted as a liaison between America and Poland on energy issues. Adam has been presented the Cleantech Investment Forum Pioneer Prize for his work in central Europe.
Prior to Adam's environment and renewable energy investment focus he was President of NFI Fortuna (1995-1997), Senior Banker of EBRD (1992-1995), and an associate in Salomon Brothers' M&A Department (1988-1992). Adam has a Masters Degree from the MIT Sloan School (1988), a BA from the University of Chicago (1981), and graduated from Phillips Academy at Andover (1976). Adam is a Chartered Financial Analyst.
Brittni Dixon Johnson
Co-Founder & General PartnerImpact Venture Capital
Dixon currently serves as a General Partner for Impact Venture Capital, and for more than 35 years has influenced and guided entrepreneurs, investors and executives in the computer, communications, and internet industries.
Dixon was named to the Forbes Midas List for four consecutive years and received the 2013 Special Achievement Award in VC from the International Business Forum.
He was elected to the Board of the National Venture Capital Association in 2005 serving on the Executive Committee and as Chairman in 2008/9. Under Dixon's leadership, the NVCA developed a widely embraced set of recommendations (NVCA 4-Pillar Plan) to stimulate liquidity in the U.S. venture capital industry. This plan resulted in bipartisan Congressional support for new job creation legislation and simplification of the IPO process for young emerging companies. Known as the JOBS Act, President Obama signed it into law in 2012.
Venture PartnerBP Ventures
Miriam Eaves, Venture Partner, BP Ventures which invests in businesses that support BP's core business and build a low carbon economy, including mobility. She is focused on identifying US investment opportunities in the Mobility/Transportation sector Smart Mobility. Specifically: Mobility as a Service, Intelligent Operations, Power & Storage, Bio and Low Carbon and Carbon Management.
She is the Founder and MD of the Cargile Group, a corporate development Advisory firm. Ms. Eaves is a Board Member of the WPA, a service and advocacy group for women.
She holds a BA in Environmental Studies from the University of North Carolina and an MBA from the University of Virginia.
Shinichiro (Shin) Fuse, Ph.D., joined MPM as a Principal in 2016 and is engaged in MPM's investment identification, due diligence and business development activities across our current BV2014 and OIF funds. He also supports MPM's relationship with Astellas and is a board observer for Switch Bio.
Prior to joining MPM, Shin was Director of Business Development at bluebird bio. At bluebird, he played an instrumental role in executing and managing key industry and academic partnerships in the fields of cell and gene therapy, cancer immunotherapy, and genome editing, including partnerships with Five Prime Therapeutics, Seattle Children's Research Institute, and the acquisition of Pregenen.
Previously, he was an Engagement Manager at Campbell Alliance (inVentiv Health Consulting), where he worked with clients in the life science industry to evaluate business development opportunities, develop commercialization strategies, and support new product launches. Prior to joining Campbell Alliance, Shin was an Associate at PureTech Ventures, where he focused on venture creation activities in the microbiome space and technology due diligence. Shin also serves as a columnist and contributing writer for Nikkei Biotech, the leading journal covering the biotech industry in Japan.
Shin received his Ph.D. in Microbiology and Immunology from Dartmouth College, a M.S. in Biomedical Science from the University of Tokyo, and a B.Eng. in Applied Chemistry from Keio University in Japan.
Founding PartnerSoGal Ventures
Elizabeth Galbut is the founding partner of SoGal Ventures and A-Level Capital, two start-up VC firms, which have collectively invested and advised 22 startups this year.
Elizabeth's favorite investment area is the intersection of smart design and machine learning/AI fueling major health tech innovation. Her placements include digital pathology standout Proscia, global health network MORE Health, mobile health platform eMocha, smart air detector Birdi, lab research platform Nebulab, smart water bottle HidrateSpark, medical device Sonavex, and mental health app Docz.
Prior to venture capital, Elizabeth was a Strategy Consultant at Deloitte Consulting, where she contributed to business development efforts that led to over $200M in new work.
Managing DirectorMPM Capital
Bard Geesaman, M.D., Ph.D., has been affiliated with MPM and associated portfolio companies since 2002. With broad experience investing, operating and facilitating business development globally, including in Japan, China and Israel, Bard is a Managing Director of MPM's Oncology Impact Fund (OIF) and serves as Chief Compliance Officer (CCO).
Prior to MPM, Bard founded Catalyst Medical Solutions, a medical documentation and billing eHealth company in Boston where he served as the Chief Technology Officer through the company's acquisition. After Catalyst, Bard joined Centagenetix, an MPM-founded company exploring the genetics of successful aging.
In 2006, Bard joined MPM as a Venture Partner with a major focus on founding Solasia Pharmaceuticals, based in Tokyo, Japan. Bard is also the co-founder and a board member of MPM healthcare IT startup TriNetX (big data analytics for clinical trials). Bard is passionate about innovation in health care, and in 2008 took a two year sabbatical from MPM to do non-profit work in Los Angeles at the X-Prize Foundation, where he worked on alternative models for motivating life sciences innovation.
He received a BS in neuroscience from UC Berkeley followed by concurrent degrees from Harvard Medical School and the Massachusetts Institute of Technology, with his PhD work focused on systems and computational neurobiology. Bard finished his medical training by completing a three-year medical residency at Massachusetts General Hospital.
Brandon joined Battery in 2015 and focuses on investments in business-to-business software companies across stages.
Previously, Brandon worked at Bank of America Merrill Lynch where he was part of the business planning and capital strategy/analysis team. Brandon also spent time at Bessemer Venture Partners, as an analyst in their Herzliya, Israel office.
Brandon graduated from the University of Pennsylvania with a BA in science, technology and society, with a concentration in information technologies and organizations.
Senior AssociateSV Health Investors
Jackie joined SV Health Investors in 2017 as a Senior Associate and brings nine years of science, research and business development experience.
Brandon is member of the investment team at OpenView, where he identifies and engages with potential portfolio companies for the firm. OpenView is a Venture Capital firm investing in expansion stage software companies, helping build companies like Instructure, Kareo, DataDog and Expensify into market leaders. He is passionate about partnering with entrepreneurs who are making technology more accessible and using it to improve people's working lives.
Brandon has previous experience at a bulge bracket investment banking firm and graduated from Cornell University, majoring in Applied Economics. He is also a pianist, trained in jazz and classical: in his spare time, he supports Music & Youth, a Boston-based organization, which creates accessible, sustainable, high quality music programs so every young person can experience music as an art form and outlet.
Managing PartnerAnzu Partners
Whitney Haring-Smith is an entrepreneur and investor focused primarily on industrial businesses. As a Managing Partner at Anzu Partners, he leads the portfolio support functions and has led most of Anzu's acquisitions.
Previously, Mr. Haring-Smith was a Principal at The Boston Consulting Group where he focused on energy, industrial goods, and globalization. Mr. Haring-Smith was also the co-founder & board chairman of College Abacus, a website that became the "Kayak.com of college financial aid" in the US.
He earned his Bachelor's and Master's degrees simultaneously from Yale University, magna cum laude, and received his doctorate from Oxford University as a Rhodes Scholar from Pennsylvania.
Investment DirectorM Ventures
Sven Harmsen, PhD, joined Merck Ventures BV, Amsterdam, The Netherlands, a subsidiary of Merck KGaA, Darmstadt, Germany, as Investment Director Performance Materials in August 2016.
Previously, Sven was working as Investment Principal at BASF Venture Capital (BVC), where he established BVC's East Coast office in Cambridge, MA to coordinate investment activities in the eastern half of North America. Sven served as a Board Director for Advanced Bionutrition (ABN) and as a Board Observer for Aspen Aerogels and SLIPS Technologies. Originally he was hired by BASF as Head of Global New Business Development for its agrochemical division.
Prior to joining BASF SE, Sven had worked for several years at a VC backed (now publicly listed) biotech company called 4SC near Munich, Germany. He started with 4SC as Head of Medicinal Chemistry and was later appointed Manager Business Development.
Following a postdoc at Stanford University Sven started his industrial career in R&D at companies like Hoechst Pharma/HMR (today: Sanofi), and AgrEvo/Aventis CropScience (today: Bayer) at sites in Germany and Japan. Sven is now based in Boston.
Managing DirectorBoehringer Ingelheim Venture Fund
Martin joined the Boehringer Ingelheim Venture Fund in 2010 to invest in early innovative therapeutic life science companies. In October 2013, Martin established the US-office of BIVF in Cambridge, MA, where he is focusing on biotech seed-investments. He has 15 years of investing and commercial experience in both venture capital and global pharma companies. He serves as board member of AMP Therapeutics in Leipzig, ArmaGen in Calabasas, 121bio in Cambridge and Sentien in Medford.
Prior to BIVF, Martin held several global roles in Marketing at Boehringer Ingelheim and Solvay Pharmaceuticals and was involved in the global launch of several products in the area of CNS. Martin began his career as an Investment Manager at Bayern Kapital, focusing on seed investments of biotech companies.
Martin holds a PhD in Biology as well as a Master degree in Biology and Economics. He serves on the board of AMP Therapeutics GmbH and ArmaGen Technologies, Inc.
Ruoxi (Rosy) Hu
Venture AssociatePartners Innovation Fund
Rosy joined Partners Innovation Fund in 2017.
Previously, Rosy was a Consultant at Clarion Healthcare, a boutique life sciences consulting firm. At Clarion, she worked with a range of clients from global pharmaceutical companies to emerging biotechs on commercial strategy for preclinical/clinical stage therapeutics in oncology, immunology, CNS, and rare diseases.
She received her PhD in Biological Sciences in Public Health from Harvard University, studying role of microRNAs in asthma pathogenesis. She received her BSc Honors in Life Sciences from Queen's University in Canada.
Vice PresidentGGV Capital
Crystal Huang is a Vice President at GGV Capital, the $3.8B US/China multi-stage venture capital firm with offices in Menlo Park, Beijing and Shanghai.
She is based in the Silicon Valley office and invests in enterprise SaaS, security and infrastructure as well as fintech. She has been involved with GGV's investments in BigCommerce, BitSight, BrightWheel, HashiCorp, OpenDoor, Restless Bandit, Tile and Wish.
Prior to joining GGV, Crystal worked as an analyst in Blackstone's Technology M&A Advisory Group, with experience in enterprise software, mobile security and ecommerce.
She graduated from Harvard College with an A.B. in Government.
AssociateHyperplane Venture Capital
Ms. Alicia Irurzun serves as Principal at Merck Ventures. She joined MS Ventures in 2014.
Alicia started her career as an analyst in global business development and licensing in 2010 at Merck Serono in Geneva. In this role she was responsible for search and evaluation efforts across therapeutic areas. Subsequently, she transitioned as a manager for global licensing and business development activities in immunology and fertility.
Over the past years, Alicia has been involved on numerous business development and licensing transactions.
Alicia holds a Bachelor Honors in Biomedical Science from Edinburgh Napier University and a Master degree in Bio-pharmaceutical Sciences and Science-based-business from Leiden University. She is based in Boston.
InvestorBessemer Venture Partners
Vinay Iyengar is an investor based in Bessemer Venture Partners' NYC office focused on machine intelligence, cyber security, and vertical SaaS.
He got his start in venture capital at Clayton Christensen's Rose Park Advisors, leading the firm's exploration of machine intelligence as an enabler of disruption. Previously, he spent time at Goldman Sachs and Intel and founded a Harvard Innovation Lab-backed enterprise software startup. He also has conducted extensive cryptography research leading to two peer-reviewed publications.
When not nerding out about technology and startups, Vinay enjoys trying new foods, listening to hip-hop, and cheering on his hometown Portland Trail Blazers. He studied computer science and economics at Harvard.
Senior AssociateHighland Capital Partners
Vice PresidentJohnson and Johnson Innovation
Dr. Kadhiresan has more than a decade of operational experience in various functional roles including research, product development, and business development.
Before joining JJDC, as head of Business Development at Guidant, Inc., now Boston Scientific, Inc., Dr. Kadhiresan led several transactions to access novel medical device technologies with venture investments, M&As, licensing and joint ventures. Prior to entering business development, he led the research and development of multiple early-stage technologies and products in cardiac rhythm management and heart failure. Dr. Kadhiresan was instrumental in the development of the cardiac resynchronization therapy for heart failure, now a multi-billion dollar worldwide market. At Heart Rhythm Technologies, a subsidiary of Guidant, he led the development of an ablation technology for treatment of atrial fibrillation and raised venture financing for the project. In addition, Dr. Kadhiresan is an inventor on more than 40 patents and has published several articles in peer-reviewed journals.
Dr. Kadhiresan received a PhD and Master of Science in Biomedical Engineering from the University of Michigan, Ann Arbor, a Master of Business Administration from the Kellogg School of Management at Northwestern University, and a Bachelor of Science in Electrical Engineering from the National Institute of Technology (REC), Trichy, India.
Managing DirectorGolden Seeds
Deb Kemper is Managing Director and Operating Committee Chair of the Boston Forum of Golden Seeds, a national angel investor group. She is a member of CEVG and on the Advisory Board of Red Bear Angels.
Her investment focus is high growth companies in the clean tech, health care, and technology sectors. She is Board Observer at 99DegreesCustom and Day One Response, as serve on several non-profit boards including the Council of Advisors of USA Girl Scouts Overseas. Deb worked at McKinsey & Company where she served clients in the energy, electronics, and healthcare sectors. Her functional experience spans manufacturing, product development, operations, and strategy.
Deb earned her MBA from the Tuck School of Business at Dartmouth College and holds a BS in Engineering from Cornell where she was a member of the Varsity Women's Crew. She spent eight years living in Peru and China prior to moving to Boston in 2013.
PrincipalRiver Cities Capital Funds
David joined River Cities as an investment professional in 2012. David focuses on the Firm's healthcare practice and works closely with portfolio companies Veran Medical, TissueTech, OrthAlign, NICO Corp., and Advanced Practice Strategies (sold), among others.
Prior to River Cities, David served as an associate with American Financial Group, a registered principal and independent investment adviser and held positions with Merrill Lynch and Procter & Gamble.
David graduated from Indiana University's Kelley School of Business and received his MBA with a concentration in finance from Xavier University's Williams College of Business.
Senior Investment ManagerDSM Venturing
Luda Kopeikina joined DSM Venturing in 2016 and is currently leading DSM investments in Solar.
Luda came to the US in 1982 from the Soviet Russia with $90 in her pocket and 40 lbs of luggage. Since then she became a VP at General Electric by implementing fifty-percent cuts in business cycles, turned around a public software company for which she was ranked in the top twenty CEOs of US high-tech companies, ahead of Bill Gates, became a serial entrepreneur and then an angel investor.
Her book "The Right Decision Every Time" based on her research into neuroscience and CEO decision making at MIT Sloan was published by Prentice Hall.
Luda holds a Master's Degree from MIT's Sloan School of Management as a Sloan Fellow. She also holds a Master's Degree in Computer Science from St. Petersburg University, Russia, and completed a Ph.D. thesis in Computer Science there.
Benjamin Kreitman broadly supports the Broadview investment team in its day-to-day operations, including identification and screening of new opportunities, due diligence, negotiation of deal structure, and portfolio company involvement.
Prior to joining Broadview, Benjamin was a Consultant at Monitor Deloitte, the strategy management consulting arm of Deloitte Consulting, LLP. At Monitor Deloitte, Benjamin worked alongside senior executives on a variety of engagements including commercial strategy development for biotechnology startups as well as global pharmaceutical and medical device manufacturers, and corporate development and investment due diligence across a number of industries.
Benjamin earned undergraduate degrees in Biological Sciences and Financial Economics Magna Cum Laude from Columbia University.
Principal4BIO Capital Partners
Yury Kukushkin, Ph.D., is a principal associate at 4BIO Capital. He focuses on biotechnology and healthcare investments, with special focus on advanced therapeutics (gene and cell therapy).
Prior to 4BIO Capital, Yury was an associate with RBV Capital, a venture fund at which he was responsible for life science investments. Specifically, Yury worked on Retrosense Therapeutics (sold to Allergan). Previously, he worked for Abercade Consulting, a boutique consulting company focusing on market research and investments valuations. Yury focused on venture deals and analysis for the U.S. and E.U. biotech markets.
He is a trained scientist, holding a Ph.D. from the Max Planck Institute of Biochemistry / Ludwig-Maximilians-Universität, Munich, Germany. He studied neurodegenerative diseases in a Lasker award-winning laboratory. His undergraduate studies were also in biochemistry, at Moscow State University.
General PartnerHuman Ventures
Michael Letta is the Chief Financial Officer and Chief Operating Officer at Human Ventures. Michael comes to Human Ventures from charity: water where he served as CFO. He was hired by the founder to lead various finance, operations and administrative functions through a rapid expansion of the organization from $9M to $45M in annual revenue; where headcount grew from 20 to 75 employees, and the unique supporter base from 56K to more than 700K. During this same period, collective fundraising efforts brought in more than $175M of both working capital and international investment funding. The latter will help bring more than 6M people in 24 developing countries clean, safe drinking water.
Prior to charity: water, Michael led teams at Thomson Media and Deloitte. He's a CPA and holds a BS/BA from The Ohio State University.
Executive DirectorNorthern Ontario Angels
Mary is currently the Executive Director of Northern Ontario Angels, an organization that matches Entrepreneurs with Investors across Northern Ontario. Under her guidance Northern Ontario Angels has been one of the top performing Angel Groups across the Country with over 170 deals and approximately $68.5M in private investments.
Prior to this Mary was the President/CEO of The Thunder Bay Chamber of Commerce for 10 years. She worked closely with all levels of government to ensure the growth of business and economic development opportunities throughout Northwestern Ontario.
During the 90's Mary was the General Manager, Principal Lender, and Business Consultant to over 500 businesses, for Superior North Community Corporation for 10 years. Prior to this Mary was an owner of two very successful businesses and taught business at Confederation College.
Mary was born, raised, and educated in Thunder Bay and continues to provide business advisory services to many area businesses and remains a strong advocate for business and industry.
Marissa Lowman leads the education practice at Village Capital.
Most recently, she was a Senior Fellow at Learn Capital, where she focused on product development and investment due diligence. Marissa co-founded LearnLaunch, an ed-tech accelerator, community, and co-working space in Boston. While there, she served as the Executive Director of LearnLaunch Institute, LearnLaunch's non-profit arm, where she grew the ed-tech community across New England, developed and scaled the Across Boundaries conference, and helped select incoming cohorts for the LearnLaunch Accelerator.
Marissa graduated with honors from Johns Hopkins University and received her MBA from Cornell Tech.
Managing PartnerBBG Ventures
Susan Lyne is President and Managing Partner of BBG Ventures, an early stage fund backing the new wave of female entrepreneurs using technology to re-imagine daily life.
Ms. Lyne has held leadership positions at media, technology, and entertainment companies of all sizes and stages, from startups to public companies. Before launching BBG Ventures, she was CEO of the AOL Brand Group where she oversaw AOL's unique content brands. From 2008-2013 she was CEO and then Chairman of Gilt Groupe, the innovative ecommerce company that pioneered flash sales in the United States.
She served as President and CEO of Martha Stewart Living Omnimedia (MSO) from 2004-2008. And from 1996 to 2004, Ms. Lyne worked at Disney/ABC, rising to President of ABC Entertainment where she oversaw development of shows including Desperate Housewives, Lost, and Grey's Anatomy. Ms. Lyne began her career in the magazine industry: she was Managing Editor of New Times and The Village Voice; and she created and launched Premiere Magazine, serving as Editor-in-Chief and Publication Director.
Ms. Lyne was named Publishing Executive of the Year by Advertising Age in 2006 and received a Matrix Award from New York Women In Communications.
PartnerBraemar Energy Ventures
Jiong Ma has more than 15 years of research, operating and venture capital experience in the technology industry.
Prior to joining Braemar, she was with the venture group at 3i, Lucent Technologies and Bell Labs in product portfolio strategy, new product launches for Optical and Data Networking, and R&D, She was also with Nortel Networks and a founding member of Onetta.
Dr. Ma received a Ph.D. in electrical engineering from the University of Colorado at Boulder, an M.S. in electrical engineering from the Worcester Polytechnic Institute in Massachusetts, and a B.S. in physics from Lanzhou University, China.
She is a graduate of the Kauffman Fellows Program, has published or co-authored 15 technical papers, and holds one U.S. patent. Dr. Ma serves on the boards of Aledia, Convey Computer, Fulham, Laser Light Engines, MC10, Powervation, and Storiant.
Founding PartnerQuake Capital
Brandon has past experience in finance, marketing, and entrepreneurship, and holds a degree in Communications from NYU. His most recent startup endeavor, Jozii.com, is a student based job matching service which amassed over 100,000 student users in the US.
Other startup experiences include serving as a Financial Controller for a Bitcoin Exchange and a marketing consultant for companies building out campus brand marketing campaigns. In addition to launching his own startups, Brandon has taken the time to participate in various accelerator programs, including NYU's Summer Launchpad. Even with his various commitments, Brandon has been dedicated to giving back to the University Entrepreneurship community, regularly speaking on Entrepreneurship as a guest lecturer at NYU, Pace, Penn State, and USC as well as serving as a judge for college pitch competitions which include Princeton's Tiger Launch, Global Entrepreneurship week and many more.
As a member of the Quake team, Brandon handles University Relations, Deal Flow Generation, and Partnerships. To date, Brandon is connected with over 80 University Entrepreneurship programs across the country including Columbia, MIT, and other top tier institutions, all of whom have participated in Quake's University Investor Series Program.
Managing PartnerPhystech Ventures
Olga Maslikhova is a managing partner at Phystech Ventures, an early stage venture capital firm she co-founded in 2013. She focuses preliminary on b2b companies in IoT, automotive and cybersecurity and leads investments in North America and South East Asia. Olga is serving on the boards of several Phystech Ventures-backed companies and is actively involved in business operations of most of her portfolio. She is a mentor at Techstars Mobility Detroit.
As an investor, Olga is passionate about all things mobility and helps technology entrepreneurs who develop deep tech solutions for large and densely populated cities to scale their ventures across regions & boarders. Apart from Phystech Ventures, Olga is an early investor in companies like ClassPass, VINEBOX, MelScience, Jetti and Cibando (acquired by Zomato).
Olga studies wine as her hobby and holds a number of certificates including WSET level 1, 2, and 3.
Founder & Managing DirectorCycle Capital Management
Managing DirectorClean Energy Venture Group
David Miller is Founder and Executive Managing Director of CEVG. An engineer by training, he brings over twenty years of technology startup management experience and over eighteen years of seed stage investing experience.
He has been on the board of directors or advisory board of several clean energy companies, including MyEnergy, Azima DLI, and Cambrian Innovation and has mentored many others. He also has an appointment as Research Affiliate at MIT's Sloan School of Management.
InvestorAlliance of Angels
One of the world's leading experts on how businesses can leverage key technology trends, transform organizations and to drive a competitive advantage. He is an internationally renowned business leader, entrepreneur, investor, consultant, best-selling author, and teaches at Rutgers Business School.
PrincipalInvenergy Future Fund
Juan Muldoon focuses on sourcing, evaluating, valuing, executing and managing the Fund's portfolio. He is integral to all aspects of the Fund's operations, including leading sourcing efforts, developing investment theses, driving diligence of potential investments, and supporting and monitoring portfolio companies. In addition, Muldoon is also the main interface between the Fund and partners in administration, audit and finance. Furthermore, Muldoon helped develop and manages the Fund's budget and economic model.
Prior to joining Invenergy, Muldoon worked at JPMorgan Chase, developing expertise in business analysis, multi-asset class trading, investments strategy, and portfolio management. Muldoon has also worked in venture capital, leading diligence and investments for early-stage companies in technology, financial services, consumer products, and enterprise services.
He holds an MBA from the University of Chicago and a BA, magna cum laude, from the University of Notre Dame.
T.T. Nguyen Duc
Investment DirectorPearson Affordable Learning Fund
T.T. Nguyen Duc leads venture capital investments for Pearson Affordable Learning Fund (PALF). She identifies investment opportunities for the fund and provides strategic, financial, and operational expertise to early-stage education companies in the US, Asia, Africa, and South America.
Previously, she led strategy, operations, and fundraising at online education platforms Skillshare and Chegg (IPO), and was a management consultant at Oliver Wyman.
She co-founded a medical device company while completing her B.S. Neuroscience and M.S. Management Science and Engineering degrees at Stanford University and a fellowship at Oxford University. She holds an MBA from Harvard Business School.
PartnerPanasonic Venture Group
Working in both Japan and the US, Ira has contributed to Panasonic's R&D and open innovation activities for over 16 years, the past 10 of which he has been a member of Panasonic Venture Group in Cupertino, CA.
He has broad contacts and deep knowledge of the technology roadmaps inside of Panasonic which are essential for developing corporate alliances between venture backed companies and Panasonic.
Ira earned his Ph.D. and Master's degrees at the University of California Los Angeles and his Bachelor's degree in mechanical engineering from Worcester Polytechnic University.
Dr. Sergei Petukhov is a Partner of Enso Ventures. Dr. Petukhov was a Managing Director at CLS Capital, he worked at RUSNANO investment fund and was an advisor at Kaye Scholer LLP for number of US pharmaceutical companies.
Dr. Petukhov leads Enso Ventures' biotechnology investments and serves as a board member / board observer at Enso Ventures' portfolio companies including Cavion, NeuroVia, Seres Therapeutics, Galera Therapeutics and Cellectar Biosciences.
Dr. Petukhov worked and studied at The Rockefeller University, The University of Edinburgh, The University of Cambridge and Moscow 1st Medical Academy.
Lauren Michelle Pfeifer
Lauren Pfeifer is an Associate for 500 Startups.
Prior to joining the 500 family, Lauren worked in Big Data Analytics and FinTech. In a prior life, she also worked as consultant for PwC's Tax Controversy and Dispute Resolution Practice in Washington, D.C.
Outside of work, Lauren is obsessed with cars, robotics, and aerospace. She is actively involved in engineering, rocketry, and diverse tech organizations including the MindMaker's Project and the DIYRoboCar project. For fun, she's a musician in blues/rock cover bands and enjoys learning new languages.
Lauren is a graduate of Texas A&M University and a Fulbright Alumna.
Christie is Partner and Chief of Staff of Backstage Capital. She is responsible for guiding our Crew to ensure Backstage runs smoothly towards its mission as well as joining Managing Partner, Arlan Hamilton, in making investment decisions (aka signing Headliners!)
Christie has extensive experience creating valuable partnerships between startups and Fortune 500 top 20 corporations, and joins Backstage from her role as Venture Development Manager at Verizon Ventures.
Christie holds a bachelor's degree in business administration from San Jose State University, and an MBA from University of Phoenix.
Morgan is a Principal with Genacast Ventures where his responsibilities include evaluating investment opportunities, sourcing new deals, and managing the growth of existing portfolio companies.
Prior to joining Genacast, Morgan worked at Bloomberg Beta, the venture firm backed by Bloomberg. He also spent time as a software engineer at Tapad and Market-Based Management instructor at the Charles Koch Institute. Morgan earned his BS from Northeastern University.
Managing DirectorGM Ventures
Sherwin Prior was named Managing Director, General Motors Ventures, LLC, effective September 1, 2010.
Prior to this appointment, he worked on the micro-cap to mid-cap growth platform for NorthPointe Capital, LLC in Troy, Michigan. Sherwin also worked for Morgan Stanley Investment Management in New York as a Senior Associate where he was responsible for investments in the industrials and consumer discretionary sectors of the economy.
His previous experience also includes General Motors Retail Holdings, where he was a Financial Acquisitions Analyst responsible for the valuation of dealerships; JP Morgan Chase where he was a Commercial Credit Analyst in the Asset-Based Lending Group; and Stout Risius Ross Valuation Consultants in Farmington Hills, Michigan where he was responsible for appraising middle-market companies and real estate.
He received a bachelor of business administration degree in finance from Eastern Michigan University and his master of business administration from the University of Michigan.
Investment PrincipalMotorola Solutions Venture Capital
Gopal Rajaraman is an Investment Principal with Motorola Solutions Venture Capital. In this role, Gopal identifies, executes, and manages strategic minority private equity investments for Motorola Solutions.
Prior to joining the Motorola Ventures team, Gopal spent fifteen years working within Motorola's Engineering teams in various roles from Software Developer to Lead Architect to Program Owner/Manager, managing several global teams and projects.
Gopal holds an MBA from the University of Chicago Booth School of Business with a concentration in Analytical Finance and Accounting. He also holds a Master of Science degree in Engineering from Purdue University and a B.Tech degree from the Indian Institute of Technology, Madras.
Vice PresidentHIG Capital
Jorge Ramirez is a Vice President at H.I.G. BioHealth Partners, the life sciences investment affiliate of H.I.G. Capital, and focuses on development stage and growth investments in the healthcare sector.
Previously, Jorge was with ProQuest Investments, a healthcare focused private equity firm. During his eight years with ProQuest, the firm raised and fully invested two funds totaling $625 million. He represented ProQuest as an observer or board member in several successful companies including: Eagle Pharmaceuticals (NASDAQ: EGRX); Mevion Medical Systems; Revision Optics; and Mirati Pharmaceutics: (NASDAQ: MRTX).
Jorge earned degrees in Neuroscience and Spanish literature from Amherst College, where he graduated magna cum laude. He earned an M.B.A. from Harvard Business School.
Managing DirectorEaston Capital
Lisa joined Easton Capital in 2010 when she repatriated from Bermuda.
Lisa was previously with Celtic Pharma, a Bermuda-based global biotech private equity firm where she was a founding member of the management team. Lisa's spent the last 7 years acquiring and developing a portfolio of later-stage biotech programs where she was involved with all aspects of the development process and managed Intellectual Property portfolio.
Lisa has been involved in all aspects of the investment and development process and sits on the board of electroCore, Respiratory Motion, Shimojani, and observer board role for Resolve and Perceptimed. Lisa also sits on the board at America's Best Home Healthcare, a home healthcare company.
Prior to her role with Celtic Pharma, Lisa consulted and helped launched a number of Hedge Funds and has held senior positions in the Pharma industry with Bristol Myers Squibb J&J's McNeil Consumer Products Company and Zeneca's US pharmaceutical division.
Steven Robinette is an associate at Atlas Venture, where he focuses on new investment opportunities translating basic biological discoveries into drug discovery programs. Since joining in 2015, he has been on the founding teams of two new ventures and supported 10+ Atlas investments.
Previously, Steven was an engagement manager at McKinsey & Company and a fellow in the Genome Institute at the NIH.
Steven received his PhD from Imperial College London, where he was a Marshall Scholar and an NSF Graduate Research Fellow.
Managing DirectorConnecticut Innovations
Douglas Roth is Director, Investments at Connecticut Innovations, Inc. (CI), the leading source of financing and ongoing support for Connecticut's innovative, growing companies and the state's most active early-stage investor. At CI, Douglas is responsible for sourcing new investment opportunities, evaluating and negotiating investments, serving on the boards of portfolio companies, and supporting their growth and success.
Before joining CI, Douglas gained extensive experience with early-stage businesses as an advisor, operator, and entrepreneur. He founded a consulting firm to help early-stage companies identify and assess growth opportunities, generate sustainable revenue, and manage intellectual property. Previously, as a senior consultant at a boutique management consulting firm, Douglas provided strategic intellectual property advisory services to companies in the telecommunications, information technology, and medical device industries. He advised investors in early-stage businesses, representing more than $250 million in invested capital. Early in his career, Douglas spent more than a decade in the telecommunications industry, primarily focused on international voice, data, and IP networks.
Douglas earned his BA, magna cum laude, in Economics and Mathematics from Boston University, and his MS in Electrical Engineering also from Boston University. He received an MBA from The Wharton School of the University of Pennsylvania with a concentration in Entrepreneurial and Strategic Management, where he was the commencement speaker. Douglas is a competitive distance runner and avid backpacker. He lives in Manchester, CT with his wife and two children.
As a Walnut Ventures angel investor and through Mass Challenge, Kathryn invests in and mentors Boston-area seed and early stage companies with technology-based B2B or B2C products.
Kathryn has over 30 years of experience helping B2B companies - from startups to IBM - boost the effectiveness of their sales and marketing organizations.
Kathryn was CMO on the executive team that took Phase Forward through its turnaround and successful IPO.
As GM, Kathryn helped build a $100 million nationwide Internet service for BBN Planet (later Genuity).
InvestorNew Enterprise Associates
Andrew is a Principal at NEA and is on the founding team of the firms' NYC office, where he focuses on enterprise and consumer technology investments.
Andrew is a Board Director of CCP Games, Qadium, and IONQ, and he is actively involved in NEA's investments in Code42, Curalate, Duolingo, Pocket, ThreatQuotient, and TrackMaven. Prior to NEA, Andrew was an Analyst at Blackstone in New York. In addition, Andrew co-founded Flicstart, a digital media company that was acquired in 2015.
Andrew received his MS as a Schwarzman Scholar at Tsinghua University in Beijing. He received his BA from Cornell University where he graduated with Phi Beta Kappa honors and studied Economics in the College of Arts and Sciences and Science of Earth Systems in the College of Engineering.
Andrew serves on the Advisory Council for Entrepreneurship at Cornell, is President Emeritus of the Cornell Venture Capital Club, and is a Board Member of the National Udall Scholarship Association focusing on issues related to environmental sustainability.
Managing DirectorTyson Ventures
Reese Schroeder currently serves as Managing Director of Tyson Ventures. He is responsible for building and managing the opportunity pipeline, as well as executing investment transactions.
Prior to joining Tyson Foods, Reese was with Motorola for 28 years serving as Managing Director for Motorola Ventures from 2004 until 2017. Prior to joining Motorola Ventures, Reese was a Director in Motorola's Corporate Development and Strategic Transactions Group responsible for a wide variety of M&A activity. During his tenure with Motorola, he served in various capacities in the Networks Business Unit, including Senior Manager of the Contracts Department, Commercial Strategies Manager for the International Marketing Organization, Director of Operations for the Asia Pacific business and Director of Business Development.
Prior to joining Motorola, Reese was Vice President of Sales and Administration for a Midwest-based manufacturer of chemical transportation containers. He also engaged in his own private law practice for a brief period of time.
In 1981, Reese graduated from North Central College in Naperville, Illinois in with a B.A. majoring in Political Science. He also received his J.D. from John Marshall Law School in 1984.
DirectorClean Energy Trust
Paul Seidler is the Director of Venture Development at Clean Energy Trust (CET), a Chicago-based cleantech accelerator and seed investor. Paul oversees CET's investment process and manages venture services for the fund's portfolio. He primarily focuses on startups in solar, storage, energy efficiency, and mobility, serving as a board director for GreenLancer and board observer for AllCell, Idle Smart, Igor, Lotic Labs, Nexmatix, SPLT, and Sun Number.
Prior to joining CET, Paul oversaw business development for ATFI, an advanced materials startup.
He holds a BA from the University of Michigan and an MBA from The University of Chicago Booth School of Business.
Vice PresidentIndustry Ventures
Lindsay concentrates on originating, valuing and managing primary and secondary investments in later-stage, venture-backed companies and secondary investments in venture capital funds.
Prior to Industry Ventures, Lindsay was a Principal in corporate strategy and development at Intuit, leading merger and acquisition activities for the company. Prior to Intuit, Lindsay developed private equity and investment banking industry expertise with Great Hill Partners and Bear Stearns.
Lindsay received her MBA from Harvard Business School and a BS in business administration in finance and accounting from Indiana University.
Vice PresidentNew Energy Capital Partners
Jeph Shaw, Principal at New Energy Capital, focuses on transaction origination, execution and monitoring. Jeph originally joined NEC as an Associate in 2010 and left in 2013 to pursue an MBA.
After business school, Jeph joined SunEdison, where he focused on corporate finance and treasury in the TerraForm Power and TerraForm Global “YieldCo” affiliates before returning to NEC in 2016. Earlier in his career, Jeph was an investment banking analyst focused on M&A advisory with TM Capital.
Jeph is a graduate of Tufts University (BA) and the Tuck School of Business at Dartmouth (MBA).
Managing DirectorGE Ventures
Abhishek works with Nexus, leading US-India VC firm, managing $1.2B across funds.
He is passionate about working with mission-driven founders who are aiming to build transformational companies in technology and healthcare.
Abhishek works closely with Nexus partner companies: Clover, Imagen Technologies, Cricket Health, ZenProspect, HeadOut, and Mezi.
Ishan is an Associate on the Point72 Ventures team, helping evaluate and execute investments. Ishan joined Point72 Ventures after rotating through various long/short teams within Point72, covering public companies in the technology and financial spaces.
Before joining Point72, Ishan was an investment banking analyst at Goldman Sachs. He graduated from Yale University with a BA in Economics.
An avid musician, Ishan advises the Duality School of Music, a non-profit music education program for underserved youth in his hometown of New Haven.
Claire Elizabeth Smith
North American Venture ManagerShell Technology Ventures
Carl Stjernfeldt is a Senior Lecturer at the MIT Sloan School of Management.
Carl is a member of the team at Shell Technology Ventures (STV), Shell' s corporate Venture Capital fund. Carl serves as Manager of North American Venture at Shell Technology Ventures since September 2013. STV invests in technology companies focused on the oil & gas and future energy (clean/green tech) markets, as well as IT and mobile technologies that support them. STV acts as a strategic partner and makes minority investments in select technology companies, including Shell technology spin-outs, and also acts as an LP in some externally managed venture capital funds.
Carl has 20 years' experience in managing critical business issues, mainly for high growth technology companies. Carl has served on numerous boards of successful companies including: Agito Networks (acquired by ShoreTel), Arbor Networks (acquired by Tektronix), BNI Video (acquired by Cisco), Broadbus Technologies (acquired by Motorola), Cedar Point Communications (acquired by Genband) and Tejas Networks.
As a Senior Associate at MassMutual Ventures, Charles Svirk assists the three Managing Directors, Doug Russel, Eric Emmons, and Mark Goodman, in sourcing potential investment opportunities and the management of the existing investment portfolio.
Prior to joining MassMutual Ventures, Mr. Svirk served as an Investment Associate at Clear Brook Advisors, advising on $1.3B in assets on fund investments in venture capital, private equity, hedge funds, and other illiquid strategies.
Before Clear Brook Advisors, Mr. Svirk co-founded Photos to Photos, Inc., an angel-backed mobile gaming studio located in Boston. Prior to that, Inc., Mr. Svirk served as an Associate at Siemens Venture Capital, where he helped support and source investments in Healthcare.
Mr. Svirk graduated cum laude from Northeastern University with a Bachelor of Science in Business Administration, concentrating in Finance and Entrepreneurship.
PartnerMVM Life Science Partners
Neil joined MVM in 2015. Prior to joining MVM, he was at Locust Walk Partners, executing a variety of buy- and sell-side transactions across a wide range of company types and therapeutic areas within healthcare. He was also a member of CVS Caremark's strategic development team and a consultant at Oliver Wyman.
Neil began his career at a Howard Hughes Medical Institute lab at the Wadsworth Center in Albany, NY, where he used 3D Cryo-Electron Microscopy techniques to study ribosome structures.
Neil holds an MBA in Healthcare Management from the Wharton School, University of Pennsylvania, and received his A.B. in the History of Science from Princeton University.
Senior AssociateMP Healthcare Venture Management
Laura Tadvalkar joined MP Healthcare Venture Management in 2017, where she focuses on early-stage investments in therapeutics and platform technologies.
Prior to MPH, Laura was a Manager at Clarion Healthcare, a boutique life sciences consulting firm in Boston. At Clarion, she worked with both emerging and established biopharmaceutical companies on commercial strategy for therapeutics & drug/device combinations in rare disease and oncology.
Laura holds a BS in Chemistry from Yale University and a PhD in Chemical Biology from Harvard University, where her research focused on mitochondrial physiology, disease, and role in cancer metabolism.
Sebastian Titz is Manager of New Ventures for 3M New Ventures, the corporate venture capital unit of 3M, and currently is in the process of setting up and running the operations of 3M New Ventures in North America.
Before joining 3M he earned his PhD in Science and Technology Management at the University of Naples in Italy and completed his MBA at the University of New Hampshire.
Founder & Managing DirectorHub Angel Investment Group
After Bowdoin College, David's professional career began as a research scientist at the Center for Blood Research.
After receiving his MBA from Sloan in 1987, he spent a decade at MIT raising capital from industry and facilitating technology transfer. David still holds a partial appointment at MIT's new Initiative on the Digital Economy. In 2000 he co-founded Hub Angels, a series of early stage investment funds.
David sits on several startup Boards, and is Chairman Emeritus of the Angel Capital Association. He is one of XConomy's "Top Angel Investors in New England".
Graham Walmsley, M.D., Ph.D. is an Investment Professional at Versant Ventures focused on biotechnology and healthcare investments.
Graham joined Versant after completing his training as a Physician Scientist Fellow at Stanford University School of Medicine. Graham's thesis work in the laboratories of Irving Weissman and Michael Longaker was featured in TIME Magazine and resulted in several patents as well as over 60 peer-reviewed publications in journals such as Science and Cell. At Versant, Graham helped build and launch BlueRock Therapeutics, a regenerative medicine company formed in partnership with Bayer through one of the largest series A investments in biotech history.
InvestorF-Prime Capital Partners
Kristina Wang joined F-Prime Capital as an Analyst in 2015.
Prior to F-Prime Capital, Kristina was an investment banking analyst in the Healthcare Group at Bank of America Merrill Lynch, where she focused on biotech M&A and capital markets transactions.
Kristina graduated magna cum laude from the University of Pennsylvania, where she studied Chemical Engineering and Finance.
Pelli Wang heads partnerships and investments for early and growth stage startups at SeedInvest, a leading equity crowdfunding platform and VC fund. She is excited by the global paradigm shift towards entrepreneurship innovation and is always on the hunt for the next, new thing.
Prior to joining SeedInvest, she worked at Lean Startup Machine, which is a NYC enterprise SaaS startup that was part of Techstars. She led their business development efforts in Asia / Greater China and built key partnerships with tech leaders and influencers. She also spent time in various investing roles at Capmark and Barclays Capital's investment banking group.
Patrick West is an accomplished executive, entrepreneur, and director with extensive executive management, investment and M&A experience in the healthcare technology and oil and gas / manufacturing sectors.
Patrick's early career was with Stryker Corporation where he participated in numerous M&A and JV negotiations. In 2002, Patrick founded a group of companies in the oil and gas industry, which he led as CEO through exit in 2009 to Cameron International at best-in-industry multiples. Subsequently, he has held several non-executive board positions in Europe and the US primarily with early stage companies.
In his current role, Patrick assists companies maximize enterprise and ultimately exit value as a partner at Mirus. He also continues to hold a range of non-executive board positions and provides angel investment and strategic direction to a portfolio of companies. He is a member of Maine Angels and Mass Medical Angels.
Patrick holds a bachelor's degree from DePauw University and has participated in the executive management training program at Harvard Business School.
Managing DirectorUniversity Ventures
Troy Williams is a Managing Director of University Ventures.
Prior to University Ventures, Troy was a senior executive at Macmillan where he was CEO of Macmillan Enterprise Solutions and President of Macmillan New Ventures, managing an edtech portfolio of seven companies with a focus on data and analytics, university systems and student performance and outcomes.
Troy founded and for nine years was CEO of Questia Media, an early ebook company ultimately sold to Cengage Learning.
Troy received his bachelor's degree in History, Phi Beta Kappa, from Rice University, and his law degree from the Harvard Law School where he was a member of Harvard Law Review.
Troy started his career in the mergers and acquisitions practice at Cravath, Swaine & Moore. He is on the Advisory Board of Rice University's School of Humanities. Troy focuses on investments in software and systems for universities.
President & FounderBoston Harbor Angels
Mic (Michael) Williams has been an investor for over 35 years. Whereas his primary investments and have been in commercial real estate; his previous investments have included manufacturing, mining, movies, lumber products, ships and a television enterprise. Since he founded the Boston chapter of the Boston Harbor Angels in 2004 he has invested in over twenty-five of the over 100 investments of the Boston Harbor Angels.
He spent 18 years with Coldwell Banker Commercial Group (now CBRE) in California, Arizona, and New York. He left to join Aries Enterprises as President of a large scale land development company in Colorado and Arizona and involved in the planning, development and sales of major planned communities. He was a Managing Director of Landauer (a NY real estate consulting firm) and also provided real estate investment banking services with a small private firm in NYC. He has served on many, public, private, and charitable boards.
He has been active in the angel investment community serving on panels, judging and lecturing at many seminars, events including Babson, Bentley, B.U., U.Mass, MIT, and Harvard.
Founding and Managing PartnerNewGen Capital
Lu Zhang is the Founding and Managing Partner of NewGen Capital.
Prior to starting NewGen, she was a Venture Partner at Fenox Venture Capital. She participated in over 20 investments and assist M&A of the portfolios. Lu was also the Founder and CEO of Acetone Inc. (acquired 2012), a start-up focused on non-invasive technology for the early diagnosis of Type II diabetes. She has also worked as a consultant at the United Nations Industrial Development Agency.
Lu received her M.S. in Materials Science and Engineering from Stanford University and holds several patents. She is an advisor and mentor to several innovative programs and incubators in Silicon Valley. Lu has won numerous awards and is frequently invited to speak at events.
She was recently awarded the Forbes US 30 under 30 & Featured as the Honoree of VC category. She was also awarded the Forbes Asia 30 under 30 of Finance category in the same year.
Managing DirectorSandbox Industries
Chris is a Managing Director at Sandbox Industries.
He serves as a Board Member of Aspire Health and Picwell. He also helps manage the Fund 's investments in Allay, Benestream, EveryMove and Phreesia.
Chris brings extensive negotiation and deal structure experience from his time in the real estate industry. Additionally, he gained deep operating experience while serving as the CFO of a private equity backed, technology-first consumer packaged goods company.
Chris earned an MBA from the Stanford Graduate School of Business and a BS in Finance from Arizona State University.